476
Views
10
CrossRef citations to date
0
Altmetric
Reviews

Relevance of leukemic stem cells in acute myeloid leukemia: heterogeneity and influence on disease monitoring, prognosis and treatment design

, , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Gerrit J Schuurhuis, Gert J Ossenkoppele, Angèle Kelder & Jacqueline Cloos. (2018) Measurable residual disease in acute myeloid leukemia using flow cytometry: approaches for harmonization/standardization. Expert Review of Hematology 11:12, pages 921-935.
Read now
Øystein Bruserud, Elise Aasebø, Maria Hernandez-Valladares, Galina Tsykunova & Håkon Reikvam. (2017) Therapeutic targeting of leukemic stem cells in acute myeloid leukemia – the biological background for possible strategies. Expert Opinion on Drug Discovery 12:10, pages 1053-1065.
Read now

Articles from other publishers (8)

Prashant Ramesh Tembhare. (2023) Monitoring Measurable/Minimal Residual Disease in Acute Myeloid Leukemia: Multiparametric Flow Cytometry-Based Approach. Indian Journal of Medical and Paediatric Oncology 44:06, pages 554-565.
Crossref
Igor Valentim Barreto, Flávia Melo Cunha de Pinho Pessoa, Caio Bezerra Machado, Laudreísa da Costa Pantoja, Rodrigo Monteiro Ribeiro, Germison Silva Lopes, Maria Elisabete Amaral de Moraes, Manoel Odorico de Moraes Filho, Lucas Eduardo Botelho de Souza, Rommel Mário Rodriguez Burbano, André Salim Khayat & Caroline Aquino Moreira-Nunes. (2022) Leukemic Stem Cell: A Mini-Review on Clinical Perspectives. Frontiers in Oncology 12.
Crossref
Eman Z. Kandeel, Nahla El Sharkawy, Marwa Hanafi, Mohamed Samra & Azza Kamel. (2020) Tracing Leukemia Stem Cells and Their Influence on Clinical Course of Adult Acute Myeloid Leukemia. Clinical Lymphoma Myeloma and Leukemia 20:6, pages 383-393.
Crossref
Håkon Reikvam, Elise Aasebø, Annette K. Brenner, Sushma Bartaula-Brevik, Ida Sofie Grønningsæter, Rakel Brendsdal Forthun, Randi Hovland & Øystein Bruserud. (2019) High Constitutive Cytokine Release by Primary Human Acute Myeloid Leukemia Cells Is Associated with a Specific Intercellular Communication Phenotype. Journal of Clinical Medicine 8:7, pages 970.
Crossref
Tania Martiáñez Canales, David de Leeuw, Eline Vermue, Gert Ossenkoppele & Linda Smit. (2017) Specific Depletion of Leukemic Stem Cells: Can MicroRNAs Make the Difference?. Cancers 9:12, pages 74.
Crossref
Dai Keino, Akitoshi Kinoshita, Daisuke Tomizawa, Hiroyuki Takahashi, Kohmei Ida, Hidemitsu Kurosawa, Kazutoshi Koike, Setsuo Ota, Noriyuki Iwasaki, Junya Fujimura, Yuki Yuza, Chikako Kiyotani, Shohei Yamamoto, Tomoo Osumi, Takahiro Ueda, Shinji Mochizuki, Keiichi Isoyama, Ryoji Hanada, Akio Tawa, Atsushi Manabe, Yoichi Toguchi & Akira Ohara. (2016) Residual disease detected by multidimensional flow cytometry shows prognostic significance in childhood acute myeloid leukemia with intermediate cytogenetics and negative FLT3-ITD: a report from the Tokyo Children’s Cancer Study Group. International Journal of Hematology 103:4, pages 416-422.
Crossref
Elvira Pelosi, Germana Castelli & Ugo Testa. (2015) Targeting LSCs through membrane antigens selectively or preferentially expressed on these cells. Blood Cells, Molecules, and Diseases 55:4, pages 336-346.
Crossref
Yishai Ofran & Jacob M. Rowe. (2015) Introducing minimal residual disease in acute myeloid leukemia. Current Opinion in Hematology 22:2, pages 139-145.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.